These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28986261)

  • 1. MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells.
    Shao L; Zhang B; Wang L; Wu L; Kan Q; Fan K
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1478-1484. PubMed ID: 28986261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs.
    Mackert JR; Qu P; Min Y; Johnson PF; Yang L; Lin PC
    Sci Rep; 2017 Oct; 7(1):14048. PubMed ID: 29070836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
    Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape.
    Lu C; Liu Z; Klement JD; Yang D; Merting AD; Poschel D; Albers T; Waller JL; Shi H; Liu K
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
    Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X
    J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell derived osteopontin and prostaglandin E2 synergistically promote the expansion of myeloid derived suppressor cells during the tumor immune escape phase.
    Mamand DR; Bazaz S; Mohammad DK; Saher O; Wiklander OPB; Sadeghi B; Hassan M; El-Andaloussi S; Abedi-Valugerdi M
    Int Immunopharmacol; 2024 Mar; 129():111584. PubMed ID: 38364741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matricellular proteins tune myeloid-derived suppressor cell recruitment and function in breast cancer.
    Chiodoni C; Sangaletti S; Colombo MP
    J Leukoc Biol; 2017 Aug; 102(2):287-292. PubMed ID: 28148719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
    Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
    J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Zheng Y; Tian X; Wang T; Xia X; Cao F; Tian J; Xu P; Ma J; Xu H; Wang S
    Mol Cancer; 2019 Mar; 18(1):61. PubMed ID: 30925926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
    Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
    Front Immunol; 2020; 11():585214. PubMed ID: 33613512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.
    Malaponte G; Hafsi S; Polesel J; Castellano G; Spessotto P; Guarneri C; Canevari S; Signorelli SS; McCubrey JA; Libra M
    Biochim Biophys Acta; 2016 Mar; 1863(3):483-489. PubMed ID: 26381542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells.
    Deng Y; Yang J; Luo F; Qian J; Liu R; Zhang D; Yu H; Chu Y
    Cancer Immunol Immunother; 2018 Sep; 67(9):1355-1364. PubMed ID: 29968153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
    Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
    Wang Y; Schafer CC; Hough KP; Tousif S; Duncan SR; Kearney JF; Ponnazhagan S; Hsu HC; Deshane JS
    J Immunol; 2018 Jul; 201(1):278-295. PubMed ID: 29752311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
    Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-κB-IDO pathway.
    Wang Y; Fan X; Wu X
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32530032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer.
    Liu D; You M; Xu Y; Li F; Zhang D; Li X; Hou Y
    Int Immunopharmacol; 2016 Oct; 39():265-272. PubMed ID: 27497194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden.
    Rui K; Tian J; Tang X; Ma J; Xu P; Tian X; Wang Y; Xu H; Lu L; Wang S
    Immunol Res; 2016 Aug; 64(4):931-9. PubMed ID: 26832917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
    Qu P; Wang LZ; Lin PC
    Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.